Close Menu

The Wall Street Journal reports that Congress members are pushing to transform the US FDA "by giving it broad powers to levy fines, order drug recalls and restrict drug-industry advertising," the article says. "The lawmakers say an FDA restructuring should build a much taller wall between the agency and the industry it regulates." The changes, if they happen, aren't expected to take place until next year.

 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

University of Idaho researchers model the scientific discovery process to examine the link between reproducibility and scientific truth.

A bill passed by a US House of Representatives appropriations subcommittee would give scientific agencies including the National Science Foundation boosts in funding.

Relocating USDA agencies outside of Washington, DC, may make them less effective, critics of the move tell NPR.

In PLOS this week: genes that help Borrelia burgdorferi survive in ticks, CiliaCarta collection of about 1,000 suspected cilia genes, and more.